<DOC>
	<DOCNO>NCT01342965</DOCNO>
	<brief_summary>This open-label , randomize , parallel arm study assess efficacy safety Tarceva ( erlotinib ) versus gemcitabine/cisplatin combination chemotherapy first-line treatment patient stage IIIB/IV non-small cell lung cancer epidermal growth factor receptor ( EGFR ) mutation tumours . Patients randomize receive either Tarceva 150 mg orally daily 3-week cycle gemcitabine 1250 mg/m^2 intravenously ( iv ) Days 1 8 plus cisplatin 75 mg/m^2 iv Day 1 .</brief_summary>
	<brief_title>A Study Erlotinib ( Tarceva ) Versus Gemcitabine/Cisplatin First-line Treatment Patients With Non-small Cell Lung Cancer With EGFR Mutations</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<criteria>Adult participant , ≥ 18 year age . Locally advanced recurrent ( stage IIIB ) metastatic ( stage IV ) nonsmall cell lung cancer . Presence epidermal growth factor receptor ( EGFR ) mutation tumours . Measurable disease accord Response Evaluation Criteria In Solid Tumors ( RECIST ) version 1.1 criterion . European Cooperative Oncology Group ( ECOG ) performance status ≤ 2 . Prior exposure agent direct human epidermal receptor ( HER ) axis ( eg , limited erlotinib , gefitinib , cetuximab , trastuzumab ) . Prior chemotherapy systemic antineoplastic therapy advance disease . Lack physical integrity upper gastrointestinal tract , malabsorption syndrome , inability take oral medication , active gastroduodenal ulcer disease . Any inflammatory change surface eye . ≥ Grade 2 peripheral neuropathy . History malignancy within 5 year , except adequately treat carcinoma situ cervix basal squamous cell skin cancer . Brain metastasis spinal cord compression yet definitely treat surgery and/or radiation , treat without evidence stable disease least 2 month . Human immunodeficiency virus ( HIV ) infection . Pregnant , nursing , lactate woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>